Tilray (NASDAQ:TLRY) Reports Sales Below Analyst Estimates In Q4 Earnings
Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 8.9% year on year to $211 million. On the other hand, the company’s full-year revenue guidance of $975 million at the midpoint came in 8.
Tilray Brands ( TLRY -11.88%) stock tumbled 12% through 9:50 a.m. ET after missing analyst sales forecasts in its Friday ...
Shares of Tilray Brands Inc. TLRY tumbled 10.22% to $1.23 Friday, on what proved to be an all-around poor trading session for ...
As Wall Street traders and equity markets (^DJI, ^IXIC, ^GSPC) continue digesting the December jobs data released this ...
Tilray ( (TLRY) ) has released its Q2 earnings. Here is a breakdown of the information Tilray presented to its investors.Stay Ahead of the ...
Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...
The head of Tilray Brands Inc. says he was pleased with the company’s performance in its latest quarter despite tax ...
Tilray Brands' upcoming fiscal Q2 results are expected to show revenue growth. Check out why I think investors should avoid ...
We recently published a list of 7 Best CBD Stocks To Invest In Right Now. In this article, we are going to take a look at ...
Denise Faltischek, Chief Strategy Officer and Head of International, said, "We are honored to have been selected again to supply medical cannabis to Luxembourg. This is a testament to the unwavering ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback